PrimeRFP SCOUT · Federal Contract Recompete Brief

75N91022C00013Clinical TRIALS monitoring service — Theradex Systems, Inc

Theradex Systems, Inc holds $26.3M across 2 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: SBA. Recompete timing centers on the Apr 30, 2027 PoP end — agencies typically plan 12–18 months ahead.

Nih Nci

Awarding office

Theradex Systems, Inc

Recipient

Apr 30, 2027

PoP end

$44.1M

Obligated

541715

NAICS

AN13

PSC

SBA

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

SBA

Contract number75N91022C00013

AgencyNih Nci

Awarding officeNih Nci

IncumbentTheradex Systems, Inc

UEIHFYTJGWFPMR7

NAICS541715

PSCAN13

Place of performancePRINCETON, NJ

Related solicitation75N91021R00014

PoP end (current)Apr 30, 2027

PoP end (w/ options)Apr 30, 2032

Obligated$44.1M

CLINICAL TRIALS MONITORING SERVICE is a federal SBA award for Nih Nci held by Theradex Systems, Inc. Estimated value $49.7M ($44.1M obligated). Current period of performance ends Apr 30, 2027 (potential Apr 30, 2032). Last award drew 1 bidder. Place of performance: PRINCETON, NJ. Related solicitation 75N91021R00014.

Recompete timing

Public

● Expiring in 214 days

Current PoP ends Apr 30, 2027 (214 days remaining). Agencies typically plan 12–18 months ahead — at 7.0 months out, that window is already open. The buying decision is likely already in motion.

Bonuses end Sept 30

Want the durability read on 75N91022C00013? One Pursuit Analysis, $500, inside 48 business hours.

48 business hours
$500
Credits toward the Pack

Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Theradex Systems, Inc — $26.3M obligated across 2 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$26.3M · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75N91022C00013?

75N91022C00013 (Clinical TRIALS monitoring service) is a Nih Nci award with an estimated value of $49.7M, currently held by Theradex Systems, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N91022C00013?

Nih Nci awarded 75N91022C00013 to Theradex Systems, Inc.

Who is the incumbent on 75N91022C00013?

Theradex Systems, Inc is the incumbent with $26.3M across 2 related awards in SCOUT’s public footprint. The current period of performance ends Apr 30, 2027.

When does Theradex Systems, Inc’s 75N91022C00013 come up for recompete?

SCOUT tracks a period-of-performance end of Apr 30, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75N91022C00013? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 20, 2026 · refreshed monthlyLatest procurement action Apr 27, 2026